Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: single dose NJ-39758979/ matching placebo; Drug: multi-dose JNJ-39758979 /matching placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Tobacco Dependence
Interventions: Drug: Experimental Nicotine; Drug: Nicotine Lozenge; Drug: Nicotine gum
Sponsor: Johnson & Johnson Consumer & Personal Products Worldwide
Completed - verified March 2010
Condition: Tobacco Dependence
Interventions: Drug: Experimental Nicotine; Drug: NiQuitinTM Nicotine Lozenge; Drug: Nicorette® Nicotine Gum
Sponsor: Johnson & Johnson Consumer & Personal Products Worldwide
Completed - verified March 2010
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Healthy
Intervention: Drug: Famotidine
Sponsor: Ranbaxy Laboratories Limited
Completed - verified March 2010
Condition: Smoking Cessation
Interventions: Drug: Nicotine; Drug: NiQuitin™ lozenge (Nicotine Lozenge) 2 mg; Drug: NiQuitin™ lozenge (Nicotine Lozenge) 4 mg
Sponsor: Johnson & Johnson Consumer & Personal Products Worldwide
Recruiting - verified February 2010
Condition: Healthy
Intervention: Drug: Famotidine
Sponsor: Ranbaxy Laboratories Limited
Completed - verified March 2010
Condition: Histamine Induced Itch
Interventions: Drug: B: JNJ-39758979 Matching Placebo /Placebo #2; Drug: A:JNJ-39758979/Placebo #1; Drug: C:Cetirizine/JNJ-39758979 Matching Placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not yet recruiting - verified February 2010
Condition: Stress
Intervention:
Sponsor: SPD Development Company Limited
Recruiting - verified March 2010
Condition: Hypertension
Intervention: Other: Computerized reminders on hypertension intensification
Sponsors: Brigham and Women's Hospital; Robert Wood Johnson Foundation
Not yet recruiting - verified March 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Capsular Contractures
Intervention: Drug: Trental
Sponsor: Legacy Health System
Recruiting - verified March 2010
Condition: Stool Output
Intervention:
Sponsor: Mead Johnson
Recruiting - verified March 2010
Conditions: Chronic Medical Conditions; Personal Health Records; Electronic Medical Record
Interventions: Device: Electronic (USB) Portable Health File; Device: Paper Portable Health File
Sponsors: St George Hospital, Australia; South Eastern Area Health Service; The University of New South Wales; National Health and Medical Research Council, Australia
Not yet recruiting - verified March 2009
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol; Drug: Placebo
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Influenza
Intervention:
Sponsor: QIAGEN Gaithersburg, Inc
Recruiting - verified March 2010
Condition: GERD
Intervention: Drug: esomeprazole 40 mg
Sponsors: Digestive & Liver Disease Specialists; AstraZeneca
Recruiting - verified March 2010
All Categories ... by Company » ... Johnson & Johnson 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
